Investors have bought into the promise of CRISPR technology for years. The ability to target and edit genes to treat cancer ...

Cash runway remains another focus. With a market capitalization of $1.42 billion and ongoing losses, investors will seek assurance on Intellia’s ability to fund operations through key milestones. The ...

In the biotech sphere, ARK continued its accumulation of CRISPR Therapeutics AG (NASDAQ:CRSP) by acquiring 37,075 shares worth $1.97 million. This purchase is part of a broader strategy, as ARK has ...

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

Vertex Pharmaceuticals Incorporated faces slowing Trikafta/Kaftrio sales and a stock-price divergence with peers. Click for this VRTX earnings update.

In this week’s edition of InnovationRx, we look at Jennifer Doudna’s $1 billion plan to bring Crispr gene editing to the real ...

Jacob Funds, a mutual fund company, released its fourth-quarter 2025 investor letter. A copy of the same can be downloaded here. After an optimistic quarter, equity markets corrected slightly in ...

Citi's 2026 Virtual Oncology Leadership Summit February 18, 2026 10:45 AM ESTCompany ParticipantsSamarth Kulkarni - CEO ...

Key market opportunities lie in AAV gene therapy advancements for hereditary retinal diseases. Future prospects include combination with CRISPR for precise genome editing, novel delivery platforms, ...

Detailed price information for Procter & Gamble Company (PG-N) from The Globe and Mail including charting and trades.

On Tuesday, Cathie Wood-led Ark Invest executed significant trades involving Advanced Micro Devices Inc. AMD, Broadcom Inc. AVGO , Coinbase Global Inc. COIN, and Airbnb Inc. ABNB. The AMD Trade ARK ...

ARK Invest bought 6.9M in Coinbase shares after selling earlier this month, signaling renewed interest as COIN stabilizes.